Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study

The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis

(2013) Imad M. Tleyjeh et al.   PLoS One

Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis

(2012) Chun Shing Kwok et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management

(2012) D. W. Eyre et al.   CLINICAL INFECTIOUS DISEASES

Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease

(2012) Yong Gil Kim et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

(2012) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections

(2011) Kathleen M. Mullane et al.   CLINICAL INFECTIOUS DISEASES

Using Electronic Health Information to Risk-Stratify Rates of Clostridium difficile Infection in US Hospitals

(2011) Marya D. Zilberberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Development and Validation of a Clostridium difficile Infection Risk Prediction Model

(2011) Erik R. Dubberke et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

(2010) Archie CA Clements et al.   LANCET INFECTIOUS DISEASES

Proton pump inhibitors as a risk factor for recurrence ofClostridium-difficile-associated diarrhea

(2010) Ji Won Kim   WORLD JOURNAL OF GASTROENTEROLOGY

Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection

(2009) Ajay K. Sethi et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Meta-analysis to assess risk factors for recurrent Clostridium difficile infection

(2008) K.W. Garey et al.   JOURNAL OF HOSPITAL INFECTION